Dr. Martens Income Statement

Financials in millions GBP. Fiscal year is April - March.

Millions GBP. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 29, 2026	Mar '25 Mar 30, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	764.9	787.6	877.1	1,000	908.3
Revenue Growth (YoY)	-2.88%	-10.20%	-12.32%	10.13%	17.50%
Cost of Revenue	258.9	275.9	301.9	382.2	329.5
Gross Profit	506	511.7	575.2	618.1	578.8
Selling, General & Admin	449	474.7	453	441.9	349.5
Depreciation & Amortization Expenses	-	-	-	54.2	36.7
Other Operating Expenses	-	-	-	-6.8	3.4
Total Operating Expenses	449	474.7	453	489.3	389.6
Operating Income	57	37	122.2	128.8	189.2
Interest Income	3.7	3.8	3	1.9	0.1
Interest Expense	-28	-32	-32.2	-18.7	-15.1
Total Non-Operating Income (Expense)	-24.3	-28.2	-29.2	-16.8	-15
Pretax Income	32.7	8.8	93	159.4	214.3
Provision for Income Taxes	8.9	4.3	23.8	30.5	33.1
Net Income	23.8	4.5	69.2	128.9	181.2
Net Income to Common	23.8	4.5	69.2	128.9	181.2
Net Income Growth	428.89%	-93.50%	-46.31%	-28.86%	422.19%
Shares Outstanding (Basic)	965	962	984	1,001	1,000
Shares Outstanding (Diluted)	980	974	986	1,001	1,003
Shares Change (YoY)	0.56%	-1.17%	-1.56%	-0.17%	0.25%
EPS (Basic)	0.03	0.01	0.07	0.13	0.18
EPS (Diluted)	0.02	0.01	0.07	0.13	0.18
EPS Growth	380.00%	-92.86%	-45.74%	-28.73%	417.14%
Free Cash Flow	133.5	187.9	149.7	33.1	168.9
Free Cash Flow Growth	-28.95%	25.52%	352.27%	-80.40%	13.74%
Free Cash Flow Per Share	0.14	0.19	0.15	0.03	0.17
Dividends Per Share	0.025	0.025	0.025	0.058	0.055
Dividend Growth	-	-	-56.34%	6.18%	-
Gross Margin	66.15%	64.97%	65.58%	61.79%	63.72%
Operating Margin	7.45%	4.70%	13.93%	12.88%	20.83%
Profit Margin	3.11%	0.57%	7.89%	12.89%	19.95%
FCF Margin	17.45%	23.86%	17.07%	3.31%	18.60%
EBITDA	129.6	113.8	194.5	186.9	226.1
EBITDA Margin	16.94%	14.45%	22.18%	18.68%	24.89%
EBIT	57	37	122.2	128.8	189.2
EBIT Margin	7.45%	4.70%	13.93%	12.88%	20.83%
Effective Tax Rate	27.22%	48.86%	25.59%	19.13%	15.45%